Why is it important? Where a repeat prescribing system is not being efficiently run there is an increased risk of patient harm. There will also be greater potential for wasted medicines, inefficient use of staff time and resources. Everyone has a role to play in ensuring that repeat prescribing systems are working safely, effectively and efficiently to help ensure maximum patient safety and minimum medicines waste. Identifying Patients for Review – The Scottish Therapeutics Utility The Scottish Therapeutics Utility (STU) is a computer programme that interrogates general practice clinical systems, (EMIS and InPS Vision) to populate an interactive dashboard and standardised reports on prescription items issued by an individual practice. STU can be used to help identify patients who may benefit from L1 Medication Review. STU works alongside the clinical system to provide direct access to the individual patient clinical record, to facilitate review and allow the user to make changes if required. STU is licensed by the Effective Prescribing & Therapeutics Branch at the Scottish Government and is available to practices throughout Scotland free of charge. The STU user guide is available at: The STU install guide is available at: Why is it important? Using STU to identify patients for L1 Medication Review will help ensure efficient use of staff time through identification of those patients who would most benefit from review. STU has searches available for the practice and automatically updates daily to ensure the data available is current. STU resource pack This is a resource which is aimed at helping interpret the information held within STU. This provides essential information on how to interpret the data generated and the reports available in order to help decide priorities for action. The resource pack also includes information around potential actions to help resolve the highlighted issues. The STU resource pack is available at: Guidance for Commissioners / Practice Managers The L1 review Tasks An L1 review may consist of the following tasks: Removal of Duplicate or Similar Repeat Prescription Items - A review of the patient’s repeat drugs list to identify if there are unnecessary duplicate items (identical or non-identical). Review of Duplicate Repeat Prescription Issues – A review of repeat items re-issued (not within 3 days of original issue.
Why is it important? Where a repeat prescribing system is not being efficiently run there is an increased risk of patient harm. There will also be greater potential for wasted medicines, inefficient use of staff time and resources. Everyone has a role to play in ensuring that repeat prescribing systems are working safely, effectively and efficiently to help ensure maximum patient safety and minimum medicines waste. Identifying Patients for Review – The Scottish Therapeutics Utility The Scottish Therapeutics Utility (STU) is a computer programme that interrogates general practice clinical systems, (EMIS and InPS Vision) to populate an interactive dashboard and standardised reports on prescription items issued by an individual practice. STU can be used to help identify patients who may benefit from L1 Medication Review. STU works alongside the clinical system to provide direct access to the individual patient clinical record, to facilitate review and allow the user to make changes if required. STU is licensed by the Effective Prescribing & Therapeutics Branch at the Scottish Government and is available to practices throughout Scotland free of charge. The STU user guide is available at: The STU install guide is available at: Why is it important? Using STU to identify patients for L1 Medication Review will help ensure efficient use of staff time through identification of those patients who would most benefit from review. STU has searches available for the practice and automatically updates daily to ensure the data available is current. STU resource pack This is a resource which is aimed at helping interpret the information held within STU. This provides essential information on how to interpret the data generated and the reports available in order to help decide priorities for action. The resource pack also includes information around potential actions to help resolve the highlighted issues. The STU resource pack is available at: Guidance for Commissioners / Practice Managers The L1 review Tasks An L1 review may consist of the following tasks: Removal of Duplicate or Similar Repeat Prescription Items - A review of the patient’s repeat drugs list to identify if there are unnecessary duplicate items (identical or non-identical). Review of Duplicate Repeat Prescription Issues – A review of repeat items re-issued (not within 3 days of original issue.